PRESTRELSKI STEVEN

XERS

PRESTRELSKI STEVEN serves as Chief Scientific Officer at Xeris Biopharma Holdings, Inc. (XERS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$27.2K

Net Position

Net Seller

$27.2K

Companies Traded

XERS

Active Period

Feb 2022

1 total trades

Most Recent

Sell XERS

Feb 24, 2022 · $27.2K

PRESTRELSKI STEVEN's Insider Trading at Xeris Biopharma Holdings, Inc. (XERS)

Buys

0 · $0.00

Sells

1 · $27.2K

Total Shares Bought

Total Shares Sold

11,228

XERS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 24, 2022	Sell	11,228	$2.42	$27.2K	569,780

Related Insiders

Beth Hecht

See Remarks

XERSSell · Apr 3, 2026

James Aloysius Brady

director

XERSSell · Apr 1, 2026

Steven Pieper

See Remarks

XERSSell · Jan 30, 2026

John Patrick Shannon Jr

See Remarks

XERSSell · Jan 30, 2026

Kevin McCulloch

See Remarks

XERSSell · Jan 30, 2026

JOHNSON JOHN

Director

XERSSell · Dec 19, 2025

BORMANN-KENNEDY BARBARA-JEAN ANNE

Director

XERSSell · Dec 12, 2025

PERSKY MARLA

Director

XERSSell · Sep 11, 2025

Explore More Insider Trading Data

XERS Insider Trading Activity

View all insider trades at Xeris Biopharma Holdings, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity